Table 4.
Subgroup with pT3 or pT4 disease or pN2 or pN3 disease (n= 11,361) |
Subgroup with ECE present or margin-positive disease (n = 4185) |
|||
---|---|---|---|---|
OR for receipt of radiation therapy (95% CI) | P value | OR for receipt of chemoradiation therapy (95% CI) | P value | |
Unadjusted | ||||
Age <70 y | Reference | - | Reference | - |
Age 70–79 y | 0.65 (0.59–0.71) | <.0001 | 0.46 (0.38–0.54) | <.0001 |
Age ≥80 y | 0.38 (0.33–0.42) | <.0001 | 0.17 (0.13–0.24) | <.0001 |
Adjusted* | ||||
Age < 70 y | Reference | - | Reference | - |
Age 70–79 y | 0.67 (0.61–0.75) | <.0001 | 0.50 (0.41–0.61) | <.0001 |
Age ≥80 y | 0.40 (0.35–0.45) | <.0001 | 0.19 (0.14–0.27) | <.0001 |
Abbreviations: CI = confidence interval; ECE = extracapsular extension; OR = odds ratio.
Adjusted for sex; race; year of diagnosis; comorbidity score; region of country; facility; oral cavity site; distance from facility; income; and urban, metropolitan, or rural residence.